J. Drayer

发表

Efficient transfer of chromosome-based DNA constructs into mammalian cells.

V. Oberle, G. de Jong, J. Drayer, 2004, Biochimica et biophysica acta.

A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor.

M. Mihm, G. Dranoff, A. Sober, 1997, Human gene therapy.

Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.

J. Laragh, J. Drayer, D. Case, 1976, The American journal of medicine.

Stability of a Functional Murine Satellite DNA-based Artificial Chromosome Across Mammalian Species

H. Telenius, J. Drayer, E. Csonka, 2004, Chromosome Research.

Circadian blood pressure patterns in ambulatory hypertensive patients: effects of age.

J. Drayer, M. Weber, F. Wyle, 1982, The American journal of medicine.

Impedance cardiography for determination of stroke index.

H Thurston, J. Laragh, J. Drayer, 1976, Journal of applied physiology.

Disparate Relationships Between Blood Pressure and Left Ventricular Mass in Patients With and Without Left Ventricular Hypertrophy

J. Gardin, J. Drayer, M. Weber, 1987, Hypertension.

The reliability of the measurement of plasma renin activity by radioimmunoassay.

T. Benraad, J. Drayer, J. Drayer, 1975, Clinica chimica acta; international journal of clinical chemistry.

The adrenergic inhibitors.

J. Drayer, M. Weber, W. Graettinger, 1987, The Medical clinics of North America.

The Role of the Sympathetic Nervous System in the Control of Left Ventricular Mass in Hypertension

J. Drayer, Michael A. Weber, 1985 .

Use of centrally-acting agonists in the treatment of mild hypertension in the elderly patient

J. Drayer, M. Weber, 1984 .

Mediators of Changes in Left Ventricular Mass During Antihypertensive Therapy

J. Gardin, J. Drayer, Michael A. Weber, 1983 .

Echocardiographic detection of left ventricular hypertrophy. Its usefulness as a prognostic tool in hypertensive patients.

J. Drayer, E. Zegarelli, E. C. Zegarelli, 1987, Chest.

BP as a determinant of cardiac left ventricular muscle mass.

J. Drayer, M. Weber, J. L. DeYoung, 1983, Archives of internal medicine.

Echocardiographic comparison of black and white hypertensive subjects.

A. A. Taylor, J. Gardin, J. Laragh, 1979, Journal of the National Medical Association.

Centrally Acting Antihypertensive Agents: A Brief Overview

J. Drayer, M. Weber, 1984, Journal of cardiovascular pharmacology.

Renin subgroups in essential hypertension.

J. Laragh, J. Drayer, M. Weber, 1982, Clinical and experimental hypertension. Part A, Theory and practice.

Effect of the calcium channel blocker nitrendipine on left ventricular mass in patients with hypertension

W. White, V. Smith, W. Hall, 1986, Clinical pharmacology and therapeutics.

Changes in ventricular septal thickness during diuretic therapy

J. Gardin, W. Aronow, J. Drayer, 1982, Clinical pharmacology and therapeutics.

Reproducibility of the whole-day blood pressure pattern in essential hypertension.

J. Drayer, M. Weber, F. Wyle, 1982, Clinical and experimental hypertension. Part A, Theory and practice.

Low and High Renin Essential Hypertension: A Comparison of Clinical and Biochemical Characteristics

J. Laragh, J. Drayer, M. Weber, 1981, The American journal of the medical sciences.

Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity.

J. Laragh, J. Drayer, D. Case, 1976, The American journal of medicine.

Triamterene-induced changes in aldosterone and renin values in essential hypertension. Evidence of a role for aldosterone in preventing blood pressure reduction.

J. Laragh, J. Drayer, H. Thurston, 1976, Archives of internal medicine.

The Combined Alpha‐ and Beta‐Adrenergic Blocker Labetalol and Propranolol in the Treatment of High Blood Pressure: Similarities and Differences

J. Drayer, Michael A. Weber, CAROL A. Kaufman, 1984, Journal of clinical pharmacology.

Aldosterone, sodium and potassium in essential hypertension.

T. Benraad, J. Drayer, A. Smals, 1982, Clinical and experimental hypertension. Part A, Theory and practice.

Hypertension in Patients with Diabetes Mellitus: Treatment with a Centrally Acting Agent

J. Drayer, M. Weber, M. Deitch, 1984, Journal of cardiovascular pharmacology.

Echocardiographic left ventricular hypertrophy in hypertension.

J. Gardin, J. Drayer, M. Weber, 1983, Chest.

Satellite DNA-based artificial chromosomes--chromosomal vectors.

G. de Jong, J. Drayer, C. Perez, 2000, Trends in biotechnology.

Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension.

J. Laragh, S. Chien, R. Devereux, 1984, The American journal of cardiology.

Monotherapy of essential hypertension with a converting-enzyme inhibitor.

J. Drayer, M. Weber, 1983, Hypertension.

Single-agent and combination therapy of essential hypertension.

J. Drayer, M. Weber, 1984, American heart journal.

A vasodilator that avoids renin stimulation and fluid retention: Antihypertensive treatment with trimazosin

W. Aronow, J. Drayer, M. Weber, 1982, Clinical pharmacology and therapeutics.

Renal effects of beta-adrenoceptor blockade.

J. Drayer, M. Weber, 1980, Kidney international.

Renin reactivity as a determinant of responsiveness to antihypertensive treatment.

J. Laragh, J. Drayer, D. Case, 1977, Archives of internal medicine.

Enhancement of the pressor response to norepinephrine by angiotensin in the conscious rabbit.

J. Drayer, M. Weber, B. Ricci, 1985, Life sciences.

Ambulatory Blood Pressure Monitoring

T. Kamarck, R. Devereux, F. Colardyn, 1984, Steinkopff.

MINERALOCORTICOIDS IN ESSENTIAL AND SECONDARY HYPERTENSION INTRODUCTION TO THE SYMPOSIUM

J. Drayer, Michael A. Weber, 1982 .

The Effects of Clonidine and Propranolol, Separately and in Combination, on Blood Pressure and Plasma Renin Activity in Essential Hypertension

J. Laragh, J. Drayer, M. Weber, 1978, Journal of clinical pharmacology.

Disparate patterns of aldosterone response during diuretic treatment of hypertension.

J. Laragh, J. Drayer, M. Weber, 1977, Annals of internal medicine.

A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II).

J. Laragh, J. Drayer, D. Case, 1976, The New England journal of medicine.

Phentolamine testing for alpha adrenergic participation in hypertensive patients: Independence from renin profiles

J. Drayer, M. Weber, J. H. Laragh, 1977, Clinical pharmacology and therapeutics.

Differential Effects of Diuresis and Beta‐Adrenoreceptor Blockade During Angiotensin‐Converting Enzyme Inhibition in Patients with Severe Hypertension

J. Drayer, M. Weber, J. Lipson, 1982, Journal of clinical pharmacology.

Cardiac muscle mass during vasodilation therapy of hypertension

J. Gardin, W. Aronow, J. Drayer, 1983, Clinical pharmacology and therapeutics.

The possible importance of aldosterone as well as renin in the long-term antihypertensive action of propranolol.

J. Laragh, J. Drayer, M. Weber, 1978, The American journal of medicine.

Interactions of Mineralocorticoids and Pressor Agents in Vascular Smooth Muscle

J. Drayer, M. Weber, R. Purdy, 1983, Hypertension.

Divergent blood pressure responses during short‐term sodium restriction in hypertension

J. Laragh, J. Drayer, M. Weber, 1980, Clinical pharmacology and therapeutics.

Blood pressure in normal subjects

J. Drayer, M. Weber, 1990 .

Whole-day BP monitoring in ambulatory normotensive men.

J. Drayer, M. Weber, W. Hoeger, 1985, Archives of internal medicine.

Non-invasive automated blood pressure monitoring in ambulatory normotensive men

J. Drayer, Michael A. Weber, E. R. Chard, 1984 .

Efficient in-vitro transfer of a 60-Mb mammalian artificial chromosome into murine and hamster cells using cationic lipids and dendrimers

A. Telenius, G. de Jong, J. Drayer, 2004, Chromosome Research.

Effect of long-term antihypertensive therapy on cardiac anatomy in patients with essential hypertension.

J. Gardin, J. Drayer, M. Weber, 1983, The American journal of medicine.

Echocardiographic evaluation of left ventricular hypertrophy.

J. Drayer, M. Weber, W. Baird, 1986, Journal of cardiovascular pharmacology.

DEXAMETHASONE-RESPONSIVE HYPERTENSION IN YOUNG WOMEN WITH SUPPRESSED RENIN AND ALDOSTERONE

W. Hoefnagels, T. Benraad, J. Drayer, 1978, The Lancet.

Effects of indomethacin alone and during diuretic or beta-adrenoreceptor-blockade therapy on blood pressure and the renin system in essential hypertension.

J. Laragh, J. Drayer, M. Weber, 1978, Clinical science and molecular medicine. Supplement.

Mammalian artificial chromosome pilot production facility: large-scale isolation of functional satellite DNA-based artificial chromosomes.

A. Telenius, H. Telenius, J. Drayer, 1999, Cytometry.

Effects of Beta-Adrenergic Antagonists and Diuretics on Kidney Function in Hypertensive Patients

J. Drayer, M. Weber, P. Kraut, 1984 .

Combined diuretic and sympatholytic therapy in elderly patients with predominant systolic hypertension.

J. Drayer, M. Weber, D. Gray, 1983, Chest.

Automated Blood-Pressure Measurements in the Diagnosis of Mild Hypertension

J. Drayer, Michael A. Weber, D. Brewer, 1986 .

A representative value for whole-day BP monitoring.

M. A. Weber, J. Drayer, F. Wyle, 1982, JAMA.

Disparate responses of blood pressure to adrenergic stimuli during beta blockade.

J. Drayer, M. Weber, P. Frankfort, 1985, General pharmacology.

Antihypertensive agents which inhibit sympathetic activity: potentially adverse effects of combination treatment.

J. Drayer, M. Weber, 1982, American heart journal.

Automated ambulatory blood pressure monitoring: a study in age-matched normotensive and hypertensive men.

J. Drayer, M. Weber, D. Nakamura, 1985, American heart journal.

Repetitive Blood Pressure Measurements: Clinical Issues, Techniques, and Data Analysis

J. Drayer, Michael A. Weber, D. Brewer, 1987 .

The use of short-term ambulatory blood pressure monitoring in differing forms of hypertension.

J. Drayer, M. Weber, J. L. DeYoung, 1983, Clinical and experimental hypertension. Part A, Theory and practice.

The circadian blood pressure pattern in ambulatory normal subjects.

J. Drayer, M. Weber, F. Wyle, 1984, The American journal of cardiology.

Long-term BP monitoring in the evaluation of antihypertensive therapy.

J. Drayer, M. Weber, J. L. DeYoung, 1983, Archives of internal medicine.

The role of aldosterone in the response to treatment of primary hypertension.

J. Laragh, J. Drayer, M. Weber, 1982, Clinical and experimental hypertension. Part A, Theory and practice.

Hypertension and medullary sponge kidneys in an adolescent with Beckwith-Wiedemann syndrome.

J. Laragh, J. Drayer, R. Virdis, 1977, The Journal of pediatrics.

Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension.

T. Benraad, J. Drayer, J. Festen, 1975, The American journal of cardiology.

Aspects of the activity of the renin-angiotensin system in hypertension

J. Drayer, 1975 .

Once-daily administration of acebutolol in treatment of hypertension.

J. Drayer, M. Weber, 1985, American heart journal.

Detection of low-renin hypertension; evaluation of out-patient renin-stimulating methods.

T. Benraad, J. Drayer, P. Kloppenborg, 1975, Clinical science and molecular medicine.

Nocturnal, daytime, and postural changes of plasma aldosterone before and during dexamethasone in adenomatous and idiopathic aldosteronism.

W. Hoefnagels, T. Benraad, J. Drayer, 1980, The Journal of clinical endocrinology and metabolism.

Generation of Transgenic Mice and Germline Transmission of a Mammalian Artificial Chromosome Introduced into Embryos by Pronuclear Microinjection

F. Jirik, J. Drayer, F. Pieper, 2004, Chromosome Research.

Leydig cell responsiveness to single and repeated human chorionic gonadotropin administration.

T. Benraad, J. Drayer, A. Smals, 1979, The Journal of clinical endocrinology and metabolism.

Tamoxifen Suppresses Gonadotropin-Induced 17α-Hydroxyprogesterone Accumulation in Normal Men

G. Boers, T. Benraad, J. Drayer, 1980 .

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma.

D. Neuberg, M. Mihm, A. Berns, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Clinical experience with rate-controlled delivery of antihypertensive therapy by a transdermal system.

J. Drayer, M. Weber, 1984, American heart journal.

Gene Therapy in Malignancies: Development and Clinical Applications of Autologous Tumour Vaccines

J. Drayer, 1997 .

Echocardiographic Assessment of Cardiac Anatomy and Function in Hypertensive Subjects

J. Ware, J. Gardin, J. Laragh, 1979, Circulation.

Adrenal Scintigraphy in Primary Aldosteronism

W. Hoefnagels, J. Drayer, F. Corstens, 1981, Nuklearmedizin.

Doppler Echocardiographic Assessment of Left Ventricular Systolic and Diastolic Function in Mild Hypertension

J. Gardin, W. Henry, J. Drayer, 1987, Hypertension.

Angiographic findings in homocystinuria

G. Boers, G. Rosenbusch, J. Drayer, 1983, CardioVascular and Interventional Radiology.

Pyridoxine treatment does not prevent homocystinemia after methionine loading in adult homocystinuria patients.

G. Boers, J. Drayer, F. Trijbels, 1983, Metabolism: clinical and experimental.

Symptoms, diagnostic pitfalls, and treatment of homocystinuria in seven adult patients.

J. Drayer, A. Smals, P. Kloppenborg, 1980, The Netherlands journal of medicine.

Central and peripheral blockade of the sympathetic nervous system.

J. Drayer, M. Weber, 1984, The American journal of medicine.

Diabetes insipidus in pregnancy as a first sign of a craniopharyngioma.

B. van der Wildt, J. Drayer, T. Eskes, 1980, European journal of obstetrics, gynecology, and reproductive biology.

Renin and aldosterone suppression in the antihypertensive action of clonidine.

J. Laragh, J. Drayer, D. Case, 1976, The American journal of cardiology.

Severe hypertension induced by naloxone.

E. Levin, J. Drayer, M. Weber, 1985, The American journal of the medical sciences.

Expression of a reporter gene after microinjection of mammalian artificial chromosomes into pronuclei of bovine zygotes

J. Drayer, A. Lazaris, C. Karatzas, 2001, Molecular reproduction and development.

THE ANTIHYPERTENSIVE PROPERTIES OF THE ANGIOTENSIN‐CONVERTING ENZYME INHIBITOR MOEXIPRIL GIVEN ALONE OR IN COMBINATION WITH A LOW DOSE OF A DIURETIC

J. Drayer, Michael Stimpel, Michael Weber, 1995, American journal of therapeutics.

Left Ventricular Hypertrophy and Function in High, Normal, and Low‐Renin Forms of Essential Hypertension

J. Laragh, R. Devereux, D. Savage, 1982, Hypertension.

The sympathetic nervous system in primary hypertension.

J. Drayer, M. Weber, 1982, Mineral and electrolyte metabolism.

Spironolactone and amiloride in hypertensive patients with and without aldosterone excess

W. Hoefnagels, J. Drayer, A. Smals, 1980, Clinical pharmacology and therapeutics.

MALIGNANT HYPERTENSION IN A CHILD WITH HEMOLYTIC‐UREMIC SYNDROME TREATED WITH CAPTOPRIL

J. Drayer, L. Monnens, M. D. Jong, 1981, Acta paediatrica Scandinavica.

The effects of steroid hormones on vascular tissue.

J. Drayer, M. Weber, R. Purdy, 1984, Journal of cardiovascular pharmacology.

Definition of normalcy in whole-day ambulatory blood pressure monitoring.

J. Drayer, M. Weber, 1985, Clinical and Experimental Hypertension Part A Theory and Practice.

Effects of low-dose antihypertensive therapy in elderly patients with predominant systolic hypertension.

J. Drayer, M. Weber, D. Gray, 1983, Journal of gerontology.

The Antihypertensive Effect of Lisinopril Compared to Atenolol in Patients with Mild to Moderate Hypertension

W. G. Reed, S. Oparil, M. Safar, 1987, Journal of Cardiovascular Pharmacology.

The dilemma of mild hypertension. Noninvasive evaluations of hypertensive patients.

J. Drayer, 1985, Chest.

Cardiovascular reference data base for recognizing circadian mesor- and amplitude-hypertension in apparently healthy men.

F Halberg, G Cornélissen, G. Cornelissen, 1984, Chronobiologia.

D. Neuberg, M. Mihm, A. Berns, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Interactions of Mineralocorticoids and Pressor Agents in Vascular Smooth Muscle

J. Drayer, M. Weber, R. Purdy, 1983, Hypertension.

Role of aldosterone in the antihypertensive effect of spironolactone in essential hypertension

W. Hoefnagels, T. Benraad, J. Drayer, 1978, Clinical pharmacology and therapeutics.

Effects on the renin-angiotensin system of agents acting at central and peripheral adrenergic receptors.

J. Drayer, M. Weber, F. Hubbell, 1983, Chest.